Biohaven Pharmaceutical Holding Company Ltd. Basic Shares Outstanding (Weighted Average)
Biohaven Pharmaceutical Holding Company Ltd. reported Basic Shares Outstanding (Weighted Average) of 71.04 million shares for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2022-08-05
- Biohaven Pharmaceutical Holding Company Ltd. weighted average number of shares outstanding, basic for the quarter ending 2022-06-30 was 71.04M shares, a 9.11% increase year-over-year.
- Biohaven Pharmaceutical Holding Company Ltd. weighted average number of shares outstanding, basic for the quarter ending 2022-03-31 was 70.33M shares, a 13.36% increase year-over-year.
- Biohaven Pharmaceutical Holding Company Ltd. weighted average number of shares outstanding, basic for the quarter ending 2021-12-31 was 66.13M shares, a 10.07% increase year-over-year.
- Biohaven Pharmaceutical Holding Company Ltd. weighted average number of shares outstanding, basic for the quarter ending 2021-09-30 was 65.39M shares, a 9.57% increase year-over-year.
- Biohaven Pharmaceutical Holding Company Ltd. weighted average number of shares outstanding, basic for fiscal 2021 was 64.68M shares, a 10.12% increase from fiscal 2020.
- Biohaven Pharmaceutical Holding Company Ltd. weighted average number of shares outstanding, basic for fiscal 2020 was 58.73M shares, a 21.12% increase from fiscal 2019.
- Biohaven Pharmaceutical Holding Company Ltd. weighted average number of shares outstanding, basic for fiscal 2019 was 48.49M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2022-06-30 | 71.04M shares 10-Q · filed 2022-08-05 | 70.69M shares 10-Q · filed 2022-08-05 | 69.17M shares derived: average of 3 quarters · filed 2022-08-05 | 68.22M shares derived: average of 4 quarters · filed 2022-08-05 |
| 2022-03-31 | 70.33M shares 10-Q · filed 2022-05-10 | 68.23M shares derived: average of 2 quarters · filed 2022-05-10 | 67.28M shares derived: average of 3 quarters · filed 2022-05-10 | 66.74M shares derived: average of 4 quarters · filed 2022-08-05 |
| 2021-12-31 | 66.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | 65.76M shares derived: average of 2 quarters · filed 2022-02-25 | 65.54M shares derived: average of 3 quarters · filed 2022-08-05 | 64.68M shares 10-K · filed 2022-02-25 |
| 2021-09-30 | 65.39M shares 10-Q · filed 2021-11-09 | 65.25M shares derived: average of 2 quarters · filed 2022-08-05 | 64.19M shares 10-Q · filed 2021-11-09 | 63.16M shares derived: average of 4 quarters · filed 2022-08-05 |
| 2021-06-30 | 65.11M shares 10-Q · filed 2022-08-05 | 63.58M shares 10-Q · filed 2022-08-05 | 62.41M shares derived: average of 3 quarters · filed 2022-08-05 | 61.73M shares derived: average of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | 62.04M shares 10-Q · filed 2022-05-10 | 61.06M shares derived: average of 2 quarters · filed 2022-05-10 | 60.60M shares derived: average of 3 quarters · filed 2022-05-10 | 60.14M shares derived: average of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | 60.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | 59.88M shares derived: average of 2 quarters · filed 2022-02-25 | 59.50M shares derived: average of 3 quarters · filed 2022-02-25 | 58.73M shares 10-K · filed 2022-02-25 |
| 2020-09-30 | 59.68M shares 10-Q · filed 2021-11-09 | 59.21M shares derived: average of 2 quarters · filed 2021-11-09 | 58.28M shares 10-Q · filed 2021-11-09 | |
| 2020-06-30 | 58.74M shares 10-Q · filed 2021-08-09 | 57.58M shares 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | 56.41M shares 10-Q · filed 2021-05-10 | |||
| 2019-12-31 | 48.49M shares 10-K · filed 2022-02-25 |